Antonio Antela
- Virology top 2%
- HIV Research and Treatment 18
- Infectious Diseases top 2%
- HIV/AIDS Research and Interventions 31
- HIV/AIDS drug development and treatment 22
- Emergency Medicine top 2%
- HIV-related health complications and treatments 19
- Hepatology top 5%
- Epidemiology top 10%
- HIV, Drug Use, Sexual Risk 7
- Pneumocystis jirovecii pneumonia detection and treatment 5
-
- Sex work and related issues 4
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
- Co-authors
- Santiago MorenoFernando DrondaMaria Jesús Pérez‐ElíasJosé L. CasadoAna MorenoCarmen QueredaFélix GutiérrezJuan Berenguer
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (4 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Antonio Antela
47 papers receiving 915 citations
Peers
Comparison fields: 5 of 77
- Virology 362
- Infectious Diseases 678
- Emergency Medicine 330
- Hepatology 193
- Epidemiology 391
Countries citing papers authored by Antonio Antela
This map shows the geographic impact of Antonio Antela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Antela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Antela more than expected).
Fields of papers citing papers by Antonio Antela
This network shows the impact of papers produced by Antonio Antela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Antela. The network helps show where Antonio Antela may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Antonio Antela, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 19 | |
| 2 | Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir | 2022 | 15 |
| 3 | 2022 | 1 | |
| 4 | 2021 | 34 | |
| 5 | 2020 | 5 | |
| 6 | 2019 | 6 | |
| 7 | 2019 | 1 | |
| 8 | 2018 | 0 | |
| 9 | 2014 | 14 | |
| 10 | 2012 | 24 | |
| 11 | 2012 | 106 | |
| 12 | 2011 | 11 | |
| 13 | 2008 | 2 | |
| 14 | 2008 | 7 | |
| 15 | 2006 | 16 | |
| 16 | 2006 | 3 | |
| 17 | 2003 | 17 | |
| 18 | 2003 | 5 | |
| 19 | 2002 | 8 | |
| 20 | 2001 | 18 |
About Antonio Antela
Antonio Antela is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 49 papers that have together received 947 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (31 papers), HIV/AIDS drug development and treatment (22 papers), HIV-related health complications and treatments (19 papers), HIV Research and Treatment (18 papers), HIV, Drug Use, Sexual Risk (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Sex work and related issues (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). The work is most often cited by research in Virology (362 citations), Infectious Diseases (678 citations) and Emergency Medicine (330 citations). Antonio Antela has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Santiago Moreno, Fernando Dronda, Maria Jesús Pérez‐Elías, José L. Casado, Ana Moreno, Carmen Quereda, Félix Gutiérrez, Juan Berenguer, Peré Domingo and Rafael Rubio. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.